Kenvue (US:KVUE) Financial Modeling Prepยท2025-10-28 19:09Core Insights - Kenvue Inc. (NYSE:KVUE) is facing significant legal challenges that could impact its market performance, leading to a Neutral rating from Johnson Rice with a stock price of $14.59 [1][6] Legal Challenges - Texas Attorney General Ken Paxton has filed a lawsuit against Kenvue and Johnson & Johnson, alleging concealment of information regarding Tylenol's potential links to autism and ADHD, raising safety concerns about the medication [2] - The lawsuit specifically accuses Kenvue of misleading pregnant women about the risks associated with Tylenol, claiming deceptive marketing practices that promoted the drug as safe during pregnancy [3] Market Performance - KVUE's stock price is currently at $14.64, reflecting a decrease of approximately 2.95% from the previous day, with a trading range between $14.56 and $14.93 [4] - Over the past year, KVUE has experienced significant volatility, with a high of $25.17 and a low of $14.05 [4] - The company's market capitalization is approximately $28.09 billion, with a trading volume of 7.52 million shares, indicating challenges in maintaining investor confidence [5]